Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS. Zorzella-Pezavento S F G, Chiuso-Minicucci F, França T G D, Ishikawa L L W, da Rosa L C, Colavite P M, Marques C, Ikoma M R V, Silva C L, Sartori A J Neuroimmunol. 2014 Jan 6. PMID: 24439542. Abstract CommentRecommendBookmarkWatch